Inventor · disambiguated record
Mark Richard Stewart
Also filed as: STEWART MARK · STEWART MARK RICHARD
13 granted patents·8 pending applications·14 citations·filing 2007–2025
86Inventor score
Files withAZURA OPHTHALMICS LTD10JIA HAIYAN3DOMAINEX LTD2NRG THERAPEUTICS LTD1PERRIOR TREVOR ROBERT1
Top patents by PatentIndex Score
21 records- 0194US10875845B2Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2020·Granted Dec 29, 2020·4 cites·20 claims
- 0286US11459351B1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2021·Granted Oct 4, 2022·1 cites·16 claims
- 0384US11634411B2Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2020·Granted Apr 25, 2023·1 cites·1 claims
- 0478US2025042931A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2024·Application pending·0 cites
- 0574US2023357207A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2023·Application pending·0 cites
- 0672US8962609B2Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing themPERRIOR TREVOR ROBERT·Filed 2011·Granted Feb 24, 2015·5 cites·21 claims
- 0772US2023348517A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2023·Application pending·0 cites
- 0871US2022332749A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2022·Application pending·0 cites
- 0969US11643429B2Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2021·Granted May 9, 2023·0 cites·20 claims
- 1066US8158789B2Arginine derivatives with NP-I antagonistic activityJIA HAIYAN·Filed 2007·Granted Apr 17, 2012·1 cites·9 claims
- 1163US9433622B2Pyrimidine compounds useful in the treatment of diseases mediated by IKKE and/or TBK1 mechanismsDOMAINEX LTD·Filed 2014·Granted Sep 6, 2016·2 cites·22 claims
- 1256US2024158375A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2021·Application pending·0 cites
- 1354US2023399317A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2021·Application pending·0 cites
- 1448US12491185B2Inhibitors of mPTPNRG THERAPEUTICS LTD·Filed 2025·Granted Dec 9, 2025·0 cites·30 claims
- 1548US8227606B2Arginine derivatives with NP-1 antagonistic activityJIA HAIYAN·Filed 2012·Granted Jul 24, 2012·0 cites·14 claims
- 1645US2012269864A1Arginine Derivatives with NP-I Antagonistic ActivityJIA HAIYAN·Filed 2012·Application pending·0 cites
- 1744US11058686B25-(pyrimidin-4-yl)-2-(pyrrolidin-1-yl)nicotinonitrile compounds as IKKE, TBK1 and/or SIK2 kinases inhibitorsDOMAINEX LTD·Filed 2018·Granted Jul 13, 2021·0 cites·24 claims
- 1844US8637453B2Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their useST GEORGES HOSP MEDICAL SCHOOL·Filed 2013·Granted Jan 28, 2014·0 cites·92 claims
- 1936US12336991B2Factor XIIA inhibitorsUNIV LEEDS INNOVATIONS LTD·Filed 2019·Granted Jun 24, 2025·0 cites·20 claims
- 2032US2021087172A1FACTOR XIIa INHIBITORSUNIVESITY OF LEEDS·Filed 2019·Application pending·0 cites
- 2131US8541363B2Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their useROBINSON CLIVE·Filed 2011·Granted Sep 24, 2013·0 cites·66 claims
Join the waitlist — get patent alerts
Get an alert when Mark Richard Stewart files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →